Reference
Country
Publication year
Period
Total N
IPOE N
IPOE rate (%)
IPOE rate with IC antibiotics
IPOE rate without IC antibiotics (%)
Romero (5)
Spain
2006
2001–2004
7268
25
0.344
0.055% (cefazolin)
0.63
ESCRS (4)
Multiple (EU countries)
2007
2003–2005
15,971
20
0.12
0.05% (cefuroxime)
0.35
Yu-Wai-Man (6)
UK
2008
2000–2006
36,743
35
0.095
0.046% (cefuroxime)
0.139
Garat (7)
Spain
2009
2002–2007
18,579
31
0.167
0.047% (cefazolin)
0.422
Garcia-Saenz (8)
Spain
2010
1999–2008
13,652
42
0.30
0.590%
(cefuroxime)
0.043
Barreau (9)
France
2012
2003–2008
5115
36
0.704
0.044% (cefuroxime)
1.238
Friling (10)
Sweden
2013
2005–2010
464,996
135
0.029
0.027%
(various)
0.39
Rodriguez-Caravaca (11)
Spain
2013
1998–2012
19,463
44
0.23
0.039% (cefuroxime)
0.59
Beselga (12)
Portugal
2014
2005–2011
15,689
6
0.038
0.00% (cefuroxime)
0.26
Rahman and Murphy (13)
Ireland
2015
2007–2011
8239
5
0.061
0.061% (cefuroxime)
–
Lundstrom (14)
Sweden
2015
2001–2010
692,786
244
0.035
0.03%
(various, 99% cefuroxime)
0.43
Creuzot-Garcher (15)
France
2016
2005–2014
6,371,242
6668
0.105
0.046%–0.111%
(cefuroxime)
0.080–0.46
Daien (16)
France
2016
2010–2014
2,434,008
1941
0.08
0.06%
(cefuroxime)
0.09
Intravitreal injections (IVI) (mainly of the anti-VEGF agents) are an increasingly commonly performed procedure. In Europe, most of IVIs are performed in the operating room (OR), while in the USA, the vast majority of specialists perform injections in an office setting. The reported incidence for endophthalmitis after IVIs in several European countries does not exceed 0.06% (Table 5.2) [18–26].
Table 5.2
Endophthalmitis rate after IVI
Reference | Country | Publication year | Period | Total N of IVI | Endophthalmitis N | Endophthalmitis rate |
---|---|---|---|---|---|---|
McCannel (18) | USA | 2011 | 2005–2009 | 105,536 | 52 | 0.049% |
Lommatzsch (19) | Germany | 2013 | 2008–2012 | N/aa | 27 | N/aa |
Tabandeh (20) | Italy and USA | 2014 | 2009–2011 | 11,710 | 5 | 0.043% |
Casparis (21) | Switzerland | 2014 | 2004–2012 | 40,011 | 3 | 0.0075% |
Fileta (22) | Multiple | 2014 | 2005–2012 | 350,535 | 197 | 0.056% |
Brynskov (23) | Denmark | 2014 | 2007–2013 | 20,293 | 0 | 0% |
Nentwich (24) | Germany | 2014 | 2005–2012 | 18,202 | 3 | 0.016% |
Dossarps (25) | France | 2014 | 2008–2013 | 316,576 | 65 | 0.021% |
Ramel (26) | France | 2015 | 2007–2012 | 11,450 | 6 | 0.052% |
Glaucoma surgery (blebs, glaucoma valve placements) also can cause postoperative endophthalmitis. Estimated incidence of bleb-related endophthalmitis (BRE) is <0.1% in case of early-onset and 0.2% for late-onset endophthalmitis [27, 28]. It has been shown that the BRE incidence rate is higher with adjunctive antimetabolites (up to 3%) [29] and when the bleb is placed inferiorly (up to 9.4%) [30].
Endogenous endophthalmitis (EE) is highly uncommon (approximately 2–8% of all cases of endophthalmitis) and is usually associated with other risk factors of systemic infection, such as diabetes, indwelling catheters, intravenous drug administration, malignancy, and immunodeficiency [31]. Because of the rarity, there are no available large-scale studies on the EE etiology, treatment options, and clinical outcomes of these patients.
Endophthalmitis: Etiology
Endophthalmitis may be caused by the microorganisms derived from conjunctival sac, contaminated devices, irrigating solutions, the implanted intraocular lens, or airborne contamination. The Endophthalmitis Vitrectomy Study has shown that in 67.7% of cases with bacterial postoperative endophthalmitis, the intraocular isolates were indistinguishable from the conjunctival and lid specimens [1]. Microbial spectrum of postoperative endophthalmitis varies in different countries and is dependent on environmental, geographical, or climatic factors. Table 5.3 presents the etiology of postoperative endophthalmitis in different regions. Gram-positive bacteria, including Staphylococcus epidermidis, Staphylococcus aureus, and Streptococcus pneumonia, are the most commonly isolated organisms from endophthalmitis occurring after cataract surgery in Europe; the gram-negative bacteria represent up to 14% of cases [9, 13, 32, 33]. There are, however, significant differences in a rate of enterococcal infections in Sweden (30–31%) and other European countries (2% in the Netherlands and UK), or the USA (3%). This shift in the preponderance of enterococcal endophthalmitis in Sweden may be connected with widespread use of intracameral cefuroxime and increased proportion of cefuroxime-resistant species. In the USA, as in Europe, the most commonly identified microorganisms are coagulase-negative Staphylococci (CONS), whereas the rate of streptococcal infections is lower [34]. In countries such as Taiwan, India, and China, the reported percentage of gram-negative and fungal cases are much higher than in Europe and the USA [35–38]. It has been shown that the bacterial virulence level is the main prognostic factor predictive of the final visual result [39].
Table 5.3
Pathogens causing postoperative endophthalmitis in different countries
Pathogens | Lundstrom (13) Sweden | Friling (9) Sweden | Mollan (28) UK | Pijl (29) Netherlands | Han (30) USA | Cheng (31) Taiwan | Anand (32) India | Kunimoto (33) India | Sheng (34) China |
---|---|---|---|---|---|---|---|---|---|
Gram-positive organisms | 44% | 37.6% | 53% | 74% | |||||
Staphylococci | 35% | ||||||||
Staphylococcus aureus | 5% | 12% | 10% | 24% | 8% | 12% | |||
Coagulase-negative Staphylococcus (CoNS) | 26% | 62% | 54% | 70% | 3% | 13% | 33% | 46% | |
Enterococci | 30% | 31% | 3% | 2% | 2% | 12% | 2% | 7% | |
Other gram-positive organisms | 13.5% | 6% | 3% | 5% | 3% | 3% | 11% | 3% | |
Streptococci | 7% | 20% | 19% | 9% | 3% | 4% | 10% | 6% | |
Gram-negative organisms (Pseudomonas sp., Enterobacteriaceae sp.)
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |